Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 10/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.59 |
| ▸ | RAB9A | P51151 | 7/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.59 |
| ▸ | NPC1 | O15118 | 6/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | LMNA | P02545 | 4/20 | 0.59 |
| ▸ | HPGD | P15428 | 4/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | POLB | P06746 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | TP53 | P04637 | 6/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4368880 | 0.84 | MMP2 (0.60) | MAPTSMN1; SMN2RAB9AKDM4ENPC1 | |
| SCHEMBL6092686 | 0.84 | MAPT (0.51) | MAPTSMN1; SMN2RAB9AKDM4ENPC1 | |
| SCHEMBL6092352 | 0.82 | SMN1; SMN2 (0.53) | MAPTSMN1; SMN2RAB9AKDM4ENPC1 | |
| SCHEMBL4371759 | 0.80 | MAPT (0.59) | MAPTSMN1; SMN2RAB9AKDM4ENPC1 | |
| SCHEMBL6093781 | 0.80 | MAPT (0.53) | MAPTSMN1; SMN2RAB9AKDM4ENPC1 | |
| SCHEMBL4371270 | 0.80 | NR2E3 (0.59) | MAPTSMN1; SMN2RAB9AKDM4ENPC1 | |
| SCHEMBL6092024 | 0.79 | SMN1; SMN2 (0.51) | MAPTSMN1; SMN2RAB9AKDM4ENPC1 | |
| SCHEMBL4372123 | 0.79 | ALDH1A1 (0.49) | MAPTSMN1; SMN2RAB9AKDM4ENPC1 | |
| SCHEMBL4372536 | 0.78 | MAPT (0.50) | MAPTSMN1; SMN2RAB9AKDM4ENPC1 | |
| SCHEMBL6090851 | 0.78 | MAPT (0.50) | MAPTSMN1; SMN2RAB9AKDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060036098-A1 | Carbonylamino-benzimidazole derivatives as androgen receptor modulators | MERCK SHARP & DOHME CORP. | 2006-02-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060036098-A1 | Carbonylamino-benzimidazole derivatives as androgen receptor modulators | AR, SHBG, BRCA1 | MAPT 2814/4885SMN1; SMN2 2413/4885RAB9A 4310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.